Bruker Corporation

bruker.com

What Do They Do?

Sells scientific instruments and analytical and diagnostic solutions to research organizations, pharmaceutical and biotechnology companies, and industrial, clinical and government customers.

How Do They Make Money?

Customers pay for instruments, accessories and parts when they ship or are accepted; service work is earned as performed or over maintenance and extended-warranty terms.

revenue

Segment	Share	Revenue	How money arrives
Product revenue Sold outright	81% FY2022: 83%		Sold outright
Service and other revenue Mix	20% FY2022: 17%		Mix

Who Are Their Customers?

Research organizations, pharmaceutical and biotechnology companies, and clinical, industrial and government users buy its instruments and solutions. Bruker sells directly in many markets and uses distributors and independent sales representatives in some regions.

Do Revenues Turn Into Profits?

Not on paper. It lost $8.6M in FY2025, but brought in more cash than it spent: $43.3M of free cash flow.

Operating income, FY2025

2% of revenue

▼ −73% vs FY2024 ($253.1M, 8%)

Net income, FY2025

0% of revenue

▼ Now a loss vs FY2024 ($113.1M, 3%)

Free cash flow, FY2025

1% of revenue

▼ −68% vs FY2024 ($136M, 4%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: ▲ +5%; vs $797.4M in Q2 FY2025
Net income: ▼ Now a loss; vs $7.6M in Q2 FY2025

Product share of revenue vs 79.6% in Q2 FY2025

Aug 4, 2026 Bruker updates fiscal 2026 revenue and earnings guidance The outlook calls for $3.54 to $3.57 billion in revenue and $2.10 to $2.15 in non-GAAP earnings per share.

Growing. Revenue grew 42% in 4 years, from $2.4B in FY2021 to $3.4B in FY2025, about 9% a year.

Automated PCR diagnostics The latest report adds the InGenius and BeGenius sample-to-answer systems, which automate extraction, PCR and data interpretation, extending the older report’s description of PCR diagnostic solutions.

Revenue over time

Product revenue Service and other revenue Service

$5B$2.5B$0

FY2021 FY2022 FY2023 FY2024 FY2025

Who Do They Compete With?

Competes with JEOL, QOne Instruments, Quad, Ciqtek, Magritek, Nanalysis, Oxford Instruments, PerkinElmer, Mediso, Trifoil, MR Solutions, Danaher, Agilent, GE-Healthcare, Waters, Thermo Fisher Scientific, Shimadzu, Hitachi, and Biomerieux

Comments